MX2022006738A - Tratamiento de dia y de noche y desde dentro hacia fuera que contiene colageno. - Google Patents

Tratamiento de dia y de noche y desde dentro hacia fuera que contiene colageno.

Info

Publication number
MX2022006738A
MX2022006738A MX2022006738A MX2022006738A MX2022006738A MX 2022006738 A MX2022006738 A MX 2022006738A MX 2022006738 A MX2022006738 A MX 2022006738A MX 2022006738 A MX2022006738 A MX 2022006738A MX 2022006738 A MX2022006738 A MX 2022006738A
Authority
MX
Mexico
Prior art keywords
treatment
carriers
effective amount
acceptable excipients
cosmetically
Prior art date
Application number
MX2022006738A
Other languages
English (en)
Inventor
Gual Nuria Floriach
Garcia Sara Manzanares
Original Assignee
Laboratorio Genove S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorio Genove S A filed Critical Laboratorio Genove S A
Publication of MX2022006738A publication Critical patent/MX2022006738A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88Two- or multipart kits
    • A61K2800/884Sequential application

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a una composición cosmética (a), (b) y (c) para el cuidado de la piel, que comprende: i) un tratamiento oral de día y ii) un tratamiento tópico de noche, en donde: el tratamiento (i) comprende administrar la composición cosmética oral (a): (a1) una cantidad cosméticamente eficaz de colágeno; y (a2) excipientes o portadores cosméticamente aceptables; y el tratamiento (ii) comprende aplicar: la composición cosmética tópica (b) que comprende: (b1) una cantidad cosméticamente eficaz de uno o más alfa-hidroxiácidos; y (b2) excipientes o portadores cosméticamente aceptables; seguido de: la composición cosmética (c): (c1) una cantidad cosméticamente eficaz de vitamina A; y (c2) excipientes o portadores cosméticamente aceptables. También se refiere a una composición farmacéutica (a), (b) y (c) para su uso en el tratamiento de una enfermedad o afección de la piel por deficiencia de colágeno, que comprende: i) un tratamiento oral de día y ii) un tratamiento tópico de noche, en donde: el tratamiento (i) comprende administrar la composición farmacéutica (a): (a1) una cantidad terapéuticamente eficaz de colágeno; y (a2) excipientes 15 o portadores farmacéuticamente aceptables; y el tratamiento (ii) comprende aplicar: la composición farmacéutica (b): (b1) una cantidad terapéuticamente eficaz de uno o más alfa-hidroxiácidos; y (b2) excipientes o portadores farmacéuticamente aceptables; seguido de: la composición farmacéutica tópica (c) que comprende: (c1) una cantidad terapéuticamente eficaz de vitamina A; y (c2) excipientes o portadores farmacéuticamente aceptables. La presente invención también se refiere a un kit cosmético y un producto farmacéutico que comprende la composición cosmética (a), (b) y (c) o, como alternativa, la composición farmacéutica (a), (b) y (c).
MX2022006738A 2019-12-03 2020-12-02 Tratamiento de dia y de noche y desde dentro hacia fuera que contiene colageno. MX2022006738A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19383073 2019-12-03
PCT/EP2020/084270 WO2021110748A1 (en) 2019-12-03 2020-12-02 A day-and-night and inside-outside collagen-containing treatment

Publications (1)

Publication Number Publication Date
MX2022006738A true MX2022006738A (es) 2022-08-15

Family

ID=68808265

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022006738A MX2022006738A (es) 2019-12-03 2020-12-02 Tratamiento de dia y de noche y desde dentro hacia fuera que contiene colageno.

Country Status (5)

Country Link
EP (1) EP4069188A1 (es)
DO (1) DOP2022000116A (es)
MX (1) MX2022006738A (es)
PE (1) PE20221171A1 (es)
WO (1) WO2021110748A1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010060564A1 (de) 2010-11-15 2012-05-16 Gelita Ag Verwendung von Kollagenhydrolysat zur Verbesserung der Gesundheit der menschlichen Haut, Haare und/oder Nägel

Also Published As

Publication number Publication date
PE20221171A1 (es) 2022-07-25
WO2021110748A1 (en) 2021-06-10
DOP2022000116A (es) 2022-08-15
EP4069188A1 (en) 2022-10-12

Similar Documents

Publication Publication Date Title
US8580317B2 (en) Compositions and methods for treating acne
MX2011008616A (es) Peptidos utiles en el tratamiento y/o cuidado de la piel , mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
TW201129368A (en) Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions
MX2011010859A (es) Peptidos utiles en el tratamiento y/o cuidado de la piel y/o cabello y su uso en composiciones cosmeticas o farmaceuticas.
WO2018154145A3 (en) Retinol replacement in skin treatment
BRPI0913831B8 (pt) peptídeo com a fórmula geral (i), seus estereoisômeros, suas misturas, ou seus sais cosmética ou farmaceuticamente aceitáveis, processo para a preparação de um peptídeo com a fórmula geral (i), seus estereoisômeros, suas misturas, ou seus sais cosmética ou farmaceuticamente aceitáveis e composição cosmética ou farmacêutica
DK1227820T3 (da) Oligosaccharidaldonsyrer og topisk anvendelse deraf
CO6640331A2 (es) Tratamiento anti-envejecimiento de la piel
BRPI0906064B8 (pt) peptídeo, processo para obtenção de um peptídeo de fórmula geral (i), composição cosmética ou farmacêutica e uso de um peptídeo de fórmula geral (i)
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
RU2007101538A (ru) Применение фармацевтической композиции, содержащей кальцитриол и пропионат клобетазола, для лечения псориаза
NZ586302A (en) Pre-surgical treatment using brimonidine applied topically to reduce bleeding or bruising
NZ594184A (en) Skin treatment
WO2017164609A3 (ko) 피부 재생 또는 상처 치료용 펩타이드 및 이의 용도
PH12019502874A1 (en) Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments
HUP0101710A2 (hu) Mátrix-protein kompozíciók sebgyógyulás elősegítésére
ATE482230T1 (de) Peptide, die bei der linderung von hautleiden oder der behandlung von periodentalkrankheiten wirkung zeigen
DK1089704T3 (da) Hårplejelotion til topisk anvendelse
PT2459153E (pt) Composição farmacêutica ou cosmética ou dietética tendo o efeito de favorecer a pigmentação capilar
JP2004515460A5 (es)
ES2127613T3 (es) Utilizacion de un antagonista de tnf-alfa para el tratamiento de rojeces cutaneas de origen neurogeno.
SI1635776T1 (sl) Sistemi proteinov za prenos lipidov in njihova kozmetična dermatološka uporaba
ES2124983T3 (es) Utilizacion de un antagonista de substancia p para el tratamiento de las manchas rojas cutaneas de origen neurogeno.
JP2018528259A5 (es)
MX2022006738A (es) Tratamiento de dia y de noche y desde dentro hacia fuera que contiene colageno.